Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3010812018 | Vedolizumab | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3012301018 | Vedolizumab (product) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3522693013 | Product containing vedolizumab (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3522694019 | Product containing vedolizumab | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3669121018 | Vedolizumab product | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3716978011 | Vedolizumab-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Vedolizumab-containing product | Is a | Immunomodulator-containing product | true | Inferred relationship | Some | ||
| Vedolizumab-containing product | Is a | Monoclonal antibody-containing product | true | Inferred relationship | Some | ||
| Vedolizumab-containing product | Is a | Inflammatory bowel disease drug | false | Inferred relationship | Some | ||
| Vedolizumab-containing product | Is a | Alpha-4 integrin receptor antagonist-containing product | true | Inferred relationship | Some | ||
| Vedolizumab-containing product | Has active ingredient | Vedolizumab | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Vedolizumab only product | Is a | True | Vedolizumab-containing product | Inferred relationship | Some | |
| Vedolizumab-containing product in parenteral dose form | Is a | True | Vedolizumab-containing product | Inferred relationship | Some | |
| Vedolizumab 300 mg powder for solution for injection vial | Is a | False | Vedolizumab-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR